PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15935590-5	2005	After 1 month of therapy with AchEI (Donepezil), MCP-1 levels increased in each patient.	Donepezil	37-46	C-C motif chemokine ligand 2	Homo sapiens	49-54	
16445950-7	2006	Expression and production of MCP-1 and IL-4 were significantly increased in AD subjects under therapy with the AChEI Donepezil, compared to the same AD patients at time of enrollment (P < 0.001).	Donepezil	117-126	C-C motif chemokine ligand 2	Homo sapiens	29-34	
16445950-8	2006	Our data suggest another possible explanation for the ability of Donepezil [diethyl(3,5-di-ter-butyl-4-hydroxybenzyl)phosphonate] to delay the progression of AD; in fact, Donepezil may modulate MCP-1 and IL-4 production, which may reflect a general shift towards type Th0/Th2 cytokines which could be protective in AD disease.	Donepezil	65-74	C-C motif chemokine ligand 2	Homo sapiens	194-199	
16445950-8	2006	Our data suggest another possible explanation for the ability of Donepezil [diethyl(3,5-di-ter-butyl-4-hydroxybenzyl)phosphonate] to delay the progression of AD; in fact, Donepezil may modulate MCP-1 and IL-4 production, which may reflect a general shift towards type Th0/Th2 cytokines which could be protective in AD disease.	Donepezil	171-180	C-C motif chemokine ligand 2	Homo sapiens	194-199